Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 6.16% is 72% below its 5-year average of 22.11%, near the low end of its 5-year range (0.93%–45.84%).
As of the fiscal period ended Tuesday, June 30, 2026. 66.42% below its 12-month average of 18.35%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 6.16%.
DEBT TO ASSETS RATIO
6.16%
DEBT TO ASSETS RATIO AVG TTM
18.35%
DEBT TO ASSETS RATIO AVG 3Y
27.91%
DEBT TO ASSETS RATIO AVG 5Y
22.11%
DEBT TO ASSETS RATIO AVG 10Y
17.17%
DEBT TO ASSETS RATIO AVG 15Y
12.21%
DEBT TO ASSETS RATIO AVG 20Y
6.79%
CURRENT VS TTM AVG
-66.42%
CURRENT VS 3Y AVG
-77.92%
CURRENT VS 5Y AVG
-72.13%
CURRENT VS 10Y AVG
-64.11%
CURRENT VS 15Y AVG
-49.53%
CURRENT VS 20Y AVG
-9.25%
SECTOR MEDIAN · HEALTHCARE
0.09%
median of 847 covered companies
CURRENT VS SECTOR MEDIAN
+6746.59%
vs the sector median at left
BioCardia, Inc.
Market Cap
$15.85M
Debt to Assets Ratio
6.16%
TTM Avg
18.35%
3Y Avg
27.91%
5Y Avg
22.11%
Market Cap
$15.71M
Debt to Assets Ratio
0.69%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$15.60M
Debt to Assets Ratio
1.94%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$16.18M
Debt to Assets Ratio
0.53%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$15.24M
Debt to Assets Ratio
0.29%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$16.40M
Debt to Assets Ratio
0.77%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$14.91M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$16.70M
Debt to Assets Ratio
0.14%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$16.84M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| BioCardia, Inc. (BCDA) | $15.85M | 6.16% | 18.35% | 27.91% | 22.11% |
| Allarity Therapeutics, Inc. (ALLR)vs › | $15.71M | 0.69% | N/A | N/A | N/A |
| Karyopharm Therapeutics Inc. (KPTI)vs › | $15.60M | 1.94% | N/A | N/A | N/A |
| TScan Therapeutics, Inc. (TCRX)vs › | $16.18M | 0.53% | N/A | N/A | N/A |
| Cocrystal Pharma, Inc. (COCP)vs › | $15.24M | 0.29% | N/A | N/A | N/A |
| Dyadic International, Inc. (DYAI)vs › | $16.40M | 0.77% | N/A | N/A | N/A |
| Pasithea Therapeutics Corp. (KTTA)vs › | $14.91M | 0.00% | N/A | N/A | N/A |
| Bionano Genomics, Inc. (BNGO)vs › | $16.70M | 0.14% | N/A | N/A | N/A |
| Marker Therapeutics, Inc. (MRKR)vs › | $16.84M | 0.00% | N/A | N/A | N/A |
| Palatin Technologies, Inc. (PTN)vs › | $16.89M | 0.03% | N/A | N/A | N/A |
Debt/Assets
6.2%
Debt/Equity
0.11
Current Ratio
2.09
Interest Coverage
N/A
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 6.16% |
| 2026-03-31 | 24.07% |
| 2025-12-31 | 15.47% |
| 2025-09-30 | 10.38% |
| 2025-06-30 | 35.66% |
| 2025-03-31 | 39.24% |
| 2024-12-31 | 25.54% |
| 2024-09-30 | 16.67% |
| 2024-06-30 | 39.38% |
| 2024-03-31 | 45.84% |
| 2023-12-31 | 44.02% |
| 2023-09-30 | 37.31% |
| 2023-06-30 | 23.13% |
| 2023-03-31 | 21.82% |
| 2022-12-31 | 16.65% |
| 2022-09-30 | 18.54% |
| 2022-06-30 | 15.71% |
| 2022-03-31 | 14.32% |
| 2021-12-31 | 11.88% |
| 2021-09-30 | 0.93% |
| 2021-06-30 | 1.56% |
| 2021-03-31 | 2.01% |
| 2020-12-31 | 2.62% |
| 2020-09-30 | 13.28% |
| 2020-06-30 | 10.61% |
| 2020-03-31 | 23.18% |
| 2019-12-31 | 14.87% |
| 2019-09-30 | 11.80% |
| 2019-06-30 | 50.59% |
| 2019-03-31 | 28.80% |
| 2018-12-31 | 0.00% |
| 2018-09-30 | 0.00% |
| 2018-06-30 | 0.00% |
| 2018-03-31 | 0.00% |
| 2017-12-31 | 0.00% |
| 2017-09-30 | 0.00% |
| 2017-06-30 | 0.00% |
| 2017-03-31 | 0.00% |
| 2016-12-31 | 0.00% |
| 2016-09-30 | 35.49% |
| 2016-06-30 | 46.30% |
| 2016-03-31 | 0.00% |
| 2015-12-31 | 40.88% |
| 2015-09-30 | 0.00% |
| 2015-06-30 | 0.00% |
| 2015-03-31 | 0.00% |
| 2014-12-31 | 0.00% |
| 2014-09-30 | 0.00% |
| 2014-06-30 | 0.00% |
| 2014-03-31 | 0.00% |
| 2013-12-31 | 0.00% |
| 2013-09-30 | 0.00% |
| 2013-06-30 | 0.00% |
| 2013-03-31 | 0.00% |
| 2012-12-31 | 0.00% |
| 2012-09-30 | 0.00% |
| 2012-06-30 | 0.00% |
| 2012-03-31 | 0.00% |
| 2011-12-31 | 0.00% |
| 2011-09-30 | 0.00% |
| 2011-06-30 | 0.00% |
| 2011-03-31 | 22.32% |
| 2010-12-31 | 9.20% |
| 2010-09-30 | 0.00% |
| 2010-06-30 | 0.00% |
| 2010-03-31 | 0.00% |
| 2009-12-31 | 0.00% |
| 2009-09-30 | 0.00% |
| 2009-06-30 | 0.00% |
| 2009-03-31 | 0.00% |
| 2008-12-31 | 0.00% |
| 2008-09-30 | 0.00% |
| 2008-06-30 | 0.00% |
| 2008-03-31 | 0.00% |
| 2007-12-31 | 0.00% |
| 2007-09-30 | 0.00% |
| 2007-06-30 | 0.00% |
| 2007-03-31 | 0.00% |
| 2006-12-31 | 0.00% |
| 2006-09-30 | 0.00% |
| 2006-06-30 | 0.00% |
| 2006-03-31 | 0.00% |
| 2005-12-31 | 0.00% |
| 2005-09-30 | 0.00% |
| 2005-06-30 | 0.00% |
| 2005-03-31 | 0.00% |
| 2004-12-31 | 0.00% |
| 2004-09-30 | 0.00% |
| 2004-06-30 | 0.00% |
| 2004-03-31 | 0.00% |
| 2003-12-31 | 0.00% |
| 2003-09-30 | 0.00% |
| 2003-06-30 | 0.00% |
| 2003-03-31 | 0.00% |
| 2002-12-31 | 0.00% |
| 2002-09-30 | 0.00% |
